logo
Select company
Select metric
$ -48KNet Income to Non-Controlling Interests
VS
Market
9
Sector
7
Industry
5
History
83
$ 0.62Close
$ 0.36 - $ 4.96 52-Week Range
Ticker Information

Ticker

IBO

Company Name

IMPACT BIOMEDICAL INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSEMKT

IMPACT BIOMEDICAL INC - Net Income to Non-Controlling Interests Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

IBO - Net Inc. NCI Historical data
DateNet Income to Non-Controlling Interests
6/30/2025$ -48K
3/31/2025$ -37K
12/31/2024$ -62K
9/30/2024$ -63K
6/30/2024$ -72K
3/31/2024$ -96K
12/31/2023$ -71K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • IMPACT BIOMEDICAL INC's latest trailing twelve months (TTM) Net Inc. NCI stands at $ -71K.
  • Over the past 5 years, IMPACT BIOMEDICAL INC's average Net Inc. NCI has been $ -64.14K.
  • The median Net Inc. NCI for IMPACT BIOMEDICAL INC during this period was $ -63K
  • IMPACT BIOMEDICAL INC reached its highest Net Inc. NCI over the past 5 years at $ -37K.
  • The lowest Net Inc. NCI recorded by IMPACT BIOMEDICAL INC in the same timeframe $ -96K

IMPACT BIOMEDICAL INC's Net Inc. NCI vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Net Inc. NCI Benchmarks
CompanyNet Inc. NCI
CELZ : CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC $ 0TCRT : ALAUNOS THERAPEUTICS INC $ 0ADTX : ADITXT INC $ -741.35KHSCS : HEARTSCIENCES INC $ 0PMCB : PHARMACYTE BIOTECH INC $ 0APVO : APTEVO THERAPEUTICS INC $ 0PALI : PALISADE BIO INC $ 0ACXP : ACURX PHARMACEUTICALS INC $ 0GNPX : GENPREX INC $ 0TTNP : TITAN PHARMACEUTICALS INC $ 0

Definition of Net Income to Non-Controlling Interests

[Income Statement] The portion of income which is attributable to non-controlling interest shareholders; subtracted from [ConsolInc] in order to obtain [NetInc].

IBO - Net Income to Non-Controlling Interests, Last 5 years

$ -96K

Minimum

Mar 31, 2024

$ -37K

Maximum

Mar 31, 2025

$ -64.14K

Average

$ -63K

Median

Net Inc. NCI Benchmark Analysis

The chart above depicts the distribution of Net Inc. NCI for companies in the Total Stock Market. The average Net Inc. NCI of the companies is $ 11.12M with a standard deviation of $ 136.51M.
The following table provides additional summary stats:
Net Inc. NCI in the Market:
filtered constituents4.26K
min$ -1.8B
max$ 2.94B
average$ 11.12M
median$ 0
std$ 136.51M